We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00805428
Recruitment Status : Unknown
Verified December 2008 by Clinical Hospital Center, Split.
Recruitment status was:  Recruiting
First Posted : December 9, 2008
Last Update Posted : December 9, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Condition or disease
Ulcerative Colitis

Study Design

Study Type : Observational
Estimated Enrollment : 32 participants
Observational Model: Case Control
Study Start Date : September 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
2
control group
patients with UC
patients with UC, without corticosteroid or immunosuppressive therapy


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients with UC and control group
Criteria

Inclusion Criteria:

  • endoscopic confirmed diagnosis

Exclusion Criteria:

  • corticosteroid or immunosuppressive therapy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00805428


Contacts
Contact: Jasna Ajdukovic, MSc 0917983374 jasna.ajdukovic@gmail.com

Locations
Croatia
Klinički bolnički centar Split Recruiting
Split, Croatia
Contact: Jasna Ajdukovic, MSc    0917983374    jasna.ajdukovic@gmail.com   
Sponsors and Collaborators
Clinical Hospital Center, Split
More Information

Responsible Party: Jasna Ajdukovic, General practice
ClinicalTrials.gov Identifier: NCT00805428     History of Changes
Other Study ID Numbers: UC
First Posted: December 9, 2008    Key Record Dates
Last Update Posted: December 9, 2008
Last Verified: December 2008

Additional relevant MeSH terms:
Colitis, Ulcerative
Colitis
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Inflammatory Bowel Diseases
Colonic Diseases
Intestinal Diseases